Nicolas Poirier

Chief Executive Officer presso OSE IMMUNOTHERAPEUTICS

Patrimonio netto: 1 M $ in data 31/03/2024

42 anni

Consumer Services

Health Technology

Posizioni attive di Nicolas Poirier

Società	Posizione	Inizio	Fine
OSE IMMUNOTHERAPEUTICS	Director/Board Member	26/06/2019	-
	Chief Executive Officer	07/10/2022	-
	Chief Tech/Sci/R&D Officer	31/05/2016	07/10/2022

Società	Posizione	Inizio	Fine
Effimune SA Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France.	Corporate Officer/Principal	01/01/2012	-

University of Nantes	Graduate Degree
Centre d'Etudes Supérieures de Techniques Industrielles	Undergraduate Degree
Louis Pasteur University	Graduate Degree

Distribuzione geografica

Francia

Posizioni

Settori

Consumer Services	4
Health Technology	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	1
OSE IMMUNOTHERAPEUTICS	Health Technology

Aziende private	1
Effimune SA Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France.	Health Technology

Aziende private

Health Technology